Tenet Healthcare (NYSE:THC) Stock Rating Upgraded by Wall Street Zen

Tenet Healthcare (NYSE:THC) was upgraded by investment analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Sunday.

Several other analysts also recently issued reports on THC. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research note on Monday, July 27th. UBS Group increased their price target on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Truist Financial raised their price target on Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. Robert W. Baird upped their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a research report on Tuesday, July 28th. Finally, KeyCorp decreased their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Tenet Healthcare has a consensus rating of “Buy” and a consensus price target of $273.00.

Tenet Healthcare Stock Performance

NYSE:THC opened at $278.71 on Friday. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The stock’s fifty day moving average is $222.52 and its 200 day moving average is $207.54. The firm has a market capitalization of $22.44 billion, a PE ratio of 10.75, a PEG ratio of 1.07 and a beta of 1.23. Tenet Healthcare has a fifty-two week low of $157.58 and a fifty-two week high of $283.05.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, sell-side analysts anticipate that Tenet Healthcare will post 20.97 earnings per share for the current year.

Insider Activity

In other Tenet Healthcare news, EVP Lisa Y. Foo sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $258.03, for a total transaction of $2,580,300.00. Following the transaction, the executive vice president owned 32,053 shares of the company’s stock, valued at approximately $8,270,635.59. This trade represents a 23.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Christopher S. Lynch sold 3,837 shares of the business’s stock in a transaction that occurred on Monday, July 27th. The stock was sold at an average price of $243.44, for a total transaction of $934,079.28. Following the completion of the transaction, the director directly owned 9,568 shares of the company’s stock, valued at $2,329,233.92. This trade represents a 28.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 41,375 shares of company stock valued at $9,793,347. Company insiders own 0.97% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. California State Teachers Retirement System boosted its stake in Tenet Healthcare by 18,362.2% in the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock valued at $3,533,142,000 after acquiring an additional 18,783,432 shares in the last quarter. Compass Financial Management LLC purchased a new stake in Tenet Healthcare in the second quarter valued at $57,000. AlphaGrep UK Ltd acquired a new stake in Tenet Healthcare during the second quarter worth about $344,000. BAM Wealth Management LLC increased its holdings in shares of Tenet Healthcare by 73.1% during the 2nd quarter. BAM Wealth Management LLC now owns 2,421 shares of the company’s stock valued at $453,000 after purchasing an additional 1,022 shares in the last quarter. Finally, denkapparat Operations GmbH increased its holdings in Tenet Healthcare by 37.6% in the second quarter. denkapparat Operations GmbH now owns 3,716 shares of the company’s stock valued at $695,000 after buying an additional 1,016 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.